Table 2. Multivariate analysis of metastatic small intestinal neuroendocrine tumor patients.
Variable | HR | 95% CI | P value |
---|---|---|---|
Age (years) | |||
≤50 | |||
>50 | 2.10 | 1.51–2.92 | <0.001 |
Gender | |||
Female | |||
Male | 1.02 | 0.8–1.28 | 0.81 |
Race | |||
Black/others | |||
White | 0.96 | 0.69–1.34 | 0.85 |
Year of diagnosis | |||
2000–2007 | |||
2008–2014 | 0.79 | 0.61–1.01 | 0.06 |
Tumor location | |||
NOS | |||
Duodenum | 1.39 | 0.93–2.08 | 0.09 |
Jejunum | 0.79 | 0.50–1.26 | 0.34 |
Ileum | 0.80 | 0.62–1.03 | 0.09 |
Tumor size (cm) | |||
≤2 | |||
>2 | 1.27 | 0.97–1.66 | 0.07 |
Histology | |||
Neuroendocrine | |||
Carcinoid | 0.68 | 0.54–0.86 | 0.001 |
Liver metastasis | |||
No | |||
Yes | 1.23 | 0.90–1.68 | 0.18 |
Grade | |||
I | |||
II | 1.45 | 1.11–1.91 | 0.007 |
III/IV | 3.50 | 2.54–4.83 | <0.001 |
Surgery | |||
No surgery | |||
Local resection | 0.43 | 0.32–0.59 | <0.001 |
Radical resection | 0.43 | 0.30–0.62 | <0.001 |
HR, hazard ratio; CI, confidence interval; NOS, not otherwise specified.